Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × ferumoxtran-10 × Clear all

NCT04261777 2025-06-03

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Phase 3 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT00622973 2011-10-12

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Phase 3 Completed

Urinary Bladder Neoplasms, Prostatic Neoplasms